Dr. Nilesh Shah Welcome Post
CEO’s Note
Dr. Nilesh joins us from Metropolis Healthcare: one of India’s most respected and trusted names in diagnostic excellence. Over the course of his career at Metropolis, he built a reputation for operational rigour, quality-driven leadership, and the ability to scale high-performance diagnostic systems without ever compromising on the standards that clinicians and patients depend on. That combination of experience and values makes him a natural fit for what we are building at 1Cell.ai.
What Dr. Nilesh Is Already Delivering
Since joining our team, Dr. Nilesh has hit the ground running. He has already brought sharper operational focus to our laboratory workflows, tightening turnaround times and embedding a culture of precision and accountability across our teams ensuring that every report and every result we deliver truly reflects the quality of our multi-omics science.
For our clinicians and partners, this means a faster, more reliable, and more seamlessly supported experience of working with 1Cell.ai.
Looking Ahead
With Dr. Nilesh at the helm of our operations, we are more confident than ever in our ability to scale our mission, making precision oncology accessible, actionable, and affordable for patients and clinicians worldwide.
We are excited about the chapter ahead. Welcome to the team, Dr. Nilesh!
Mohan Uttarwar
CEO, 1Cell.Ai
Meet Dr. Nilesh Shah
A Note from Dr. Nilesh
Hello. I’m Dr. Nilesh Shah, India Head at 1Cell.Ai.
I joined this company a few months ago and when I first walked into 1Cell, I saw something rare.
A team with extraordinary scientific depth. A platform built on cutting-edge multi-omics. And an honest acknowledgment — that to truly deliver impact, operations needed to be rebuilt.
Coming from my experience in diagnostics, I’ve always believed that great science only matters when it is delivered with absolute reliability. I’ve spent my career building that discipline at Metropolis. And after deep dives across multiple functions and countless interactions, one thought stayed with me:
“I saw a scientific engine that deserved a world-class operational backbone—and I knew how to build it.”
Since joining, I have initiated four charters that define how we move forward — and how we serve you better. These aren’t just promises; they’re what I’m working on every single day.
Roadmap for the Next 3 Months
Four foundational charters to elevate our operations, support, communication, and scientific translation.
Lab Operations & Workflows
Bringing diagnostic discipline in every report. By working closely with the team, we removed bottlenecks, introduced automation, and implemented global quality checks.
- Faster turnaround times
- Stronger processes
- Reliability as a standard
Always On Support
Building multiple layers of support so clinicians can serve patients seamlessly—from picking the right test to interpreting complex reports.
- Launched 1Cell Molecular Helpline
- Sales teams as scientific partners
- Monthly Molecular Tumor Board discussions
Clarity of Product Differentiation
Clearly communicating the value of our whole-genome multi-omics and AI-driven platform across every interaction, report, and proposal.
- Why a Complete Molecular Portrait matters
- Translating insights into action
- Removing clinical ambiguity
Scientific & Medical Affairs
A dedicated team to translate deep science into clinical education, real-world evidence, and true peer-to-peer partnership.
- Direct interface to deep science
- Collaboration on research & publications
- Data-backed clinical insights
Ready to Connect?
Engage directly with Dr. Nilesh Shah to discuss our operational roadmap, scientific capabilities, or potential partnerships.
© 2026 1Cell.Ai. All rights reserved.